SEC Form 5 · accession 0001388410-17-000005
PARALLAX HEALTH SCIENCES, INC. · PRLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Redmond
Officer — President · Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 18, 2017 · 8:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTIONSF2,F1 | $0.05 | Aug 13, 2015 | A | 2,000,000 | A | — | Aug 13, 2020 | COMMON STOCK | 2,000,000 | 3,375,000 | D |
Explanation of responses
- F1OPTIONS VEST QUARTERLY OVER 3 YEAR PERIOD AT 166,667 PER QUARTER BEGINNING 11/13/2015.
- F2OPTIONS GRANTED IN CONNECTION WITH EMPLOYMENT AGREEMENT DATED 08/13/2015